Which healthcare stock can dividend investors safely buy? Let's consider two excellent options: AbbVie (NYSE: ABBV) and Amgen (NASDAQ: AMGN).

Allergan first set up on a greenfield site outside Westport 47 years ago and it has provided a bonanza to the Co Mayo town.

AbbVie Migraine Career Catalyst Awardtm contest winners shared inspiring stories and professional goals, showcasing their triumphs over the challenges of living with migraine AbbVie, a leader in ...

Acquired by AbbVie in its $9 billion Cerevel Therapeutics buy ... And while much of the attention during earnings season ...

Emraclidine was expected to be a blockbuster drug for AbbVie, and this development didn’t sit well with investors.

AbbVie’s deal flop and NFL high-profile draft busts have a lot in common.

Many patients with IBD report persisting symptoms, despite resolution of the inflammatory process. Although by definition, a ...

Negative data cost AbbVie billions of dollars in market value and convinced analysts Bristol Myers had placed a better bet in ...

But I think part of the reason we're seeing such a significant sell-off is that it does bring into question the potential ...

AbbVie reports disappointing mid-stage data for its schizophrenia drug. Jason Snipe of Odyssey Capital still likes AbbVie ...

Bristol-Myers Squibb Co (NYSE:BMY) shares are trading higher Monday. The stock appears to be reacting positively after AbbVie ...